Literature DB >> 2262803

Primary central nervous system lymphoma imitates multiple sclerosis.

L M DeAngelis1.   

Abstract

Primary central nervous system lymphoma (PCNSL) can be confused with multiple sclerosis (MS) in patients who present with neurological dysfunction, a non-enhancing periventricular lesion, and CSF pleocytosis. Administration of corticosteroid causes clinical improvement and regression of PCNSL in some patients which may be interpreted as a steroid-induced remission from an exacerbation of MS. Sustained clinical dependence upon corticosteroid is unusual in MS, and should lead to consideration of PCNSL. Repeat CSF examination and gadolinium-enhanced MRI scan obtained off corticosteroid should differentiate between the two diagnostic possibilities.

Entities:  

Mesh:

Year:  1990        PMID: 2262803     DOI: 10.1007/bf02427840

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Transient CNS deficits: a common, benign syndrome in young adults.

Authors:  D E Levy
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.

Authors:  F Fazekas; H Offenbacher; S Fuchs; R Schmidt; K Niederkorn; S Horner; H Lechner
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

3.  Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients.

Authors:  E W Willoughby; E Grochowski; D K Li; J Oger; L F Kastrukoff; D W Paty
Journal:  Ann Neurol       Date:  1989-01       Impact factor: 10.422

4.  The reticulum cell sarcoma--microglioma group of brain tumours. A consideration of their clinical features and therapy.

Authors:  H H Schaumburg; C R Plank; R D Adams
Journal:  Brain       Date:  1972       Impact factor: 13.501

5.  Steroid-induced remissions in CNS lymphoma.

Authors:  A Singh; R J Strobos; B M Singh; A B Rothballer; V Reddy; S Puljic; T P Poon
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

6.  Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.

Authors:  L M DeAngelis; J Yahalom; M H Heinemann; C Cirrincione; H T Thaler; G Krol
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

7.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

8.  Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis.

Authors:  B Gametchu
Journal:  Science       Date:  1987-04-24       Impact factor: 47.728

Review 9.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

10.  Intracranial malignant lymphoma. Report of 30 cases and review of the literature.

Authors:  M Jiddane; F Nicoli; P Diaz; U Bergvall; F Vincentelli; J Hassoun; G Salamon
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

View more
  11 in total

1.  Prolonged remission of primary central nervous system lymphoma after discontinuation of steroid therapy.

Authors:  M J van den Bent; J A Vanneste; B J Ansink
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

2.  Brain lymphoma: usefulness of the magnetic resonance spectroscopy.

Authors:  Sophie Taillibert; Rémy Guillevin; Carole Menuel; Marc Sanson; Khê Hoang-Xuan; Jacques Chiras; Hugues Duffau
Journal:  J Neurooncol       Date:  2007-09-04       Impact factor: 4.130

3.  Primary central nervous system lymphoma: variety of clinical manifestations and survival.

Authors:  D G Kim; D H Nam; H W Jung; K S Choi; D H Han
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.

Authors:  J J Raizer; J A Koutcher; L E Abrey; K S Panageas; L M DeAngelis; E Lis; S Xu; K L Zakian
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

5.  Post-treatment T1 shortening in primary CNS lymphoma.

Authors:  Sasan Karimi; Vaios Hatzoglou; Vineet Punia; Sasan Partovi; Lauren E Abrey; Lisa M Deangelis
Journal:  J Neurooncol       Date:  2012-10-17       Impact factor: 4.130

Review 6.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

7.  Primary low-grade diffuse small lymphocytic lymphoma of the central nervous system.

Authors:  Mehar Aziz; Jai Kumar Chaurasia; Roobina Khan; Nishat Afroz
Journal:  BMJ Case Rep       Date:  2014-04-12

8.  Sentinel lesions of primary CNS lymphoma.

Authors:  L Alderson; M R Fetell; M Sisti; F Hochberg; M Cohen; D N Louis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

9.  The development of primary central nervous system B-cell lymphoma in multiple sclerosis.

Authors:  Mark K Lyons; Orland K Boucher; Barry D Birch; Naresh P Patel
Journal:  Neurohospitalist       Date:  2011-07

10.  Necrotizing vasculopathy of the CNS: case report.

Authors:  Martin Begemann; George Krol; Marc K Rosenblum; Lisa M Deangelis
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.